STALEY CAPITAL ADVISERS’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$968K Hold
8,045
0.04% 110
2025
Q4
$847K Hold
8,045
0.03% 119
2025
Q3
$675K Hold
8,045
0.03% 128
2025
Q2
$637K Hold
8,045
0.03% 128
2025
Q1
$722K Hold
8,045
0.03% 122
2024
Q4
$800K Hold
8,045
0.04% 119
2024
Q3
$914K Hold
8,045
0.04% 113
2024
Q2
$996K Sell
8,045
-122
-1% -$15.7K 0.05% 105
2024
Q1
$1.08M Hold
8,167
0.05% 103
2023
Q4
$890K Hold
8,167
0.04% 108
2023
Q3
$841K Sell
8,167
-399
-5% -$43K 0.05% 105
2023
Q2
$988K Buy
8,566
+15
+0.2% +$1.7K 0.05% 100
2023
Q1
$910K Hold
8,551
0.05% 104
2022
Q4
$949K Hold
8,551
0.06% 99
2022
Q3
$736K Buy
8,551
+1,142
+15% +$102K 0.05% 104
2022
Q2
$675K Hold
7,409
0.04% 108
2022
Q1
$608K Sell
7,409
-100
-1% -$7.88K 0.03% 116
2021
Q4
$575K Buy
7,509
+100
+1% +$7.96K 0.03% 119
2021
Q3
$556K Hold
7,409
0.03% 117
2021
Q2
$576K Sell
7,409
-911
-11% -$67.8K 0.03% 115
2021
Q1
$612K Sell
8,320
-773
-9% -$57K 0.03% 118
2020
Q4
$710K Hold
9,093
0.04% 102
2020
Q3
$720K Hold
9,093
0.05% 100
2020
Q2
$671K Buy
9,093
+1,013
+13% +$76.3K 0.05% 101
2020
Q1
$593K Hold
8,080
0.05% 97
2019
Q4
$701K Hold
8,080
0.05% 107
2019
Q3
$649K Buy
8,080
+4,910
+155% +$394K 0.05% 102
2019
Q2
$254K Hold
3,170
0.02% 148
2019
Q1
$252K Sell
3,170
-1,222
-28% -$91.4K 0.02% 142
2018
Q4
$320K Hold
4,392
0.03% 126
2018
Q3
$297K Hold
4,392
0.02% 135
2018
Q2
$254K Sell
4,392
-1,692
-28% -$95.5K 0.02% 142
2018
Q1
$316K Sell
6,084
-1,770
-23% -$95.6K 0.02% 118
2017
Q4
$422K Buy
7,854
+2,216
+39% +$123K 0.03% 106
2017
Q3
$344K Hold
5,638
0.03% 122
2017
Q2
$345K Sell
5,638
-157
-3% -$9.56K 0.03% 125
2017
Q1
$351K Buy
5,795
+79
+1% +$4.79K 0.03% 103
2016
Q4
$321K Hold
5,716
0.03% 102
2016
Q3
$340K Hold
5,716
0.03% 99
2016
Q2
$314K Hold
5,716
0.03% 99
2016
Q1
$289K Sell
5,716
-314
-5% -$15.4K 0.03% 104
2015
Q4
$304K Sell
6,030
-577
-9% -$29.1K 0.04% 99
2015
Q3
$311K Buy
6,607
+367
+6% +$19.5K 0.04% 100
2015
Q2
$339K Hold
6,240
0.04% 98
2015
Q1
$342K Sell
6,240
-629
-9% -$35.6K 0.04% 93
2014
Q4
$372K Hold
6,869
0.04% 91
2014
Q3
$389K Buy
6,869
+1,246
+22% +$70K 0.05% 90
2014
Q2
$310K Hold
5,623
0.04% 103
2014
Q1
$305K Hold
5,623
0.04% 103
2013
Q4
$269K Sell
5,623
-45
-0.8% -$2.06K 0.04% 104
2013
Q3
$257K Buy
5,668
+45
+0.8% +$2.06K 0.04% 99
2013
Q2
$249K Buy
+5,623
New +$251K 0.04% 93

Other funds holding MRK

STALEY CAPITAL ADVISERS's MRK Position: Q1 2026 in Review

STALEY CAPITAL ADVISERS held its Merck (MRK) position steady in Q1 2026 at 8,045 shares worth $968K. The position accounts for 0.04% of the portfolio, ranked #110.

STALEY CAPITAL ADVISERS first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.08M in Q1 2024. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • STALEY CAPITAL ADVISERS held 8,045 shares of Merck worth $968K as of Q1 2026.
  • STALEY CAPITAL ADVISERS left its Merck share count unchanged in Q1 2026.
  • Merck made up 0.04% of STALEY CAPITAL ADVISERS's portfolio in Q1 2026, its #110 holding.
  • STALEY CAPITAL ADVISERS first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • STALEY CAPITAL ADVISERS's Merck position peaked at $1.08M in Q1 2024.
  • 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on STALEY CAPITAL ADVISERS's 13F filing for Q1 2026, filed 29 Apr 2026.